Short term effectiveness of ustekinumab versus vedolizumab in Crohn's disease after failure of anti-TNF agents: An observational comparative study design with a Bayesian analysis.
Ahmed A AlamerLina H Al LehaibiMukhtar AlomarFahad AldhuwayanSaleh AlshouishAnfal Y Al-AliZakia AlmudhryAbdulaziz AlmulhimAbdulhamid AlthagafiSaad AldosariTurki AlAmeelPublished in: Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association (2024)
In CD patients with anti-TNF failure, ustekinumab was more effective than vedolizumab in the short term. These real-world insights contribute to understanding CD management but require validation in larger prospective studies and randomized controlled trials.